Related Experiment Videos
Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma
Julia Johne1, Constanze Blume, Peter M Benz
11. Institute of Clinical Biochemistry and Pathobiochemistry, Josef-Schneider-Strasse 2, University of Würzburg, D-97080 Würzburg, Germany.
Biological Chemistry
|February 25, 2006
Summary
Blood coagulation factor XII (FXII) initiates clotting and inflammation. Platelets significantly enhance FXII-driven bradykinin formation and thrombin generation, suggesting FXII cascades occur on platelet surfaces.
Area of Science:
- Biochemistry
- Hematology
- Immunology
Background:
- Blood coagulation factor XII (FXII) is a serine protease activated by negatively charged surfaces.
- FXII initiates both blood clotting (intrinsic pathway) and inflammatory responses (kallikrein-kinin system).
Purpose of the Study:
- To investigate FXII-mediated bradykinin formation and blood clotting.
- To determine the role of platelets in FXII-initiated cascades.
Main Methods:
- Western blotting using specific antibodies against contact factors.
- In vitro clotting assays to measure thrombin and fibrin formation.
Main Results:
- Limited FXII activation is sufficient for plasma kallikrein activation and bradykinin generation.
- Platelets significantly enhance FXII-initiated bradykinin formation.
- Platelets critically promote FXII-driven thrombin and fibrin formation in vitro.
Conclusions:
- FXII-initiated protease cascades, including bradykinin formation and clotting, are significantly enhanced by platelets.
- These FXII-platelet interactions may have implications for inflammatory and thrombotic processes.